eyeonics to Introduce Crystalens Five-O at AAO
Share:
eyeonics to Introduce crystalens Five-O at AAO
ALISO VIEJO, Calif., Nov. 7 // -- eyeonics, inc. (TM), the developer of the crystalens(R) is introducing the crystalens Five-O(TM). The new crystalens Five-O has been redesigned to include new features:
o The optic size has been increased from 4.5 to 5.0mm;
o The plates are parallel rather than trapezoidal;
o 17% greater surface area for contact between the optic, plates and
capsular bag;
o 90% more plate arc length.
Surgeons' preference for a larger optic led to the development of the redesign. This feature will further increase the ease with which surgeons can implant the lens. The parallel pockets will lead to greater plate motion by creation of a uniform width pocket in the capsular bag. The increase in surface area and arc length will further enhance predictability and capsular bag support. Crystalens Five-O is easily inserted with an injector through a 2.8 mm incision.
"We are excited to present our new lens at the AAO this year. We believe that the new design is giving ophthalmic surgeons what they want without comprising the pre-existing benefits of crystalens," said J. Andy Corley, President and CEO of eyeonics, inc.
Eyeonics will present the crystalens Five-O during the 2006 AAO Annual Meeting at a breakfast on Sunday, November 12 from 7:00 to 8:45 am in the Venetian Hotel. If you would like to attend, please register by contacting Kathy Kelly at eyeonics, 949-389-1790 or kkelly@eyeonics.com.
About crystalens(R)
The crystalens is the result of more than 14 years of research and development by J. Stuart Cumming, M.D., F.A.C.S., and was approved by the FDA in November 2003. During clinical trials, all of the patients who received the crystalens greatly reduced their need for corrective lenses or eyeglasses. The patented crystalens technology is designed to allow the lens to move in the eye in a manner similar to the natural lens. By using the eye's muscle to move the lens backwards and forwards naturally, patients can focus through a continuous range of vision including near, far and intermediate vision. All other intraocular lenses are designed to remain fixed in the eye. For more information about the crystalens go to crysatlens.com.
About eyeonics, inc.(TM)
eyeonics, inc. is a privately held medical device company headquartered in Aliso Viejo, Calif., founded in 1998. eyeonics is committed to developing a new class of visual enhancement systems that will enable patients to see up close, far away and all distances in between. More than 50,000 lenses have been implanted worldwide to date. For more information about eyeonics, inc., go to www.crystalens.com, "about us."
http://crysatlens.com
Web site: www.eyeonics.com
Source: eyeonics, inc.
